US stock · data to 2026-10-20
AbbVie (ABBV)
AbbVie: $288.21 on 2026-10-20. +16.5% a year since 2013, worst fall -49%. Year-by-year returns, risk profile and what followed its price patterns in the past.
Open the interactive chart and full historyKey numbers
| Last close | $288.21 |
| Return a year since 2013 | +16.5% |
| All-time high | $288.21 (2026-10-20) |
| Below its high | +0.0% |
| Worst fall | -49% (2019-08-15) |
| Yearly volatility | 26% |
| Beta vs its index | 0.66 |
| Risk / reward vs its market | Low risk · High reward |
Returns by year
| Year | Return |
|---|---|
| 2026 | +26.1% |
| 2025 | +28.6% |
| 2024 | +14.7% |
| 2023 | -4.1% |
| 2022 | +19.4% |
| 2021 | +26.4% |
| 2020 | +21.0% |
| 2019 | -4.0% |
| 2018 | -4.7% |
| 2017 | +54.4% |
| 2016 | +5.7% |
| 2015 | -9.5% |
What followed its price patterns in the past
How often ABBV was higher 40 trading days after each pattern, next to an ordinary day. History for learning, not a forecast.
| Pattern | Past cases | Higher after 40 days | On an ordinary day | Median move |
|---|---|---|---|---|
| Up streak | 64 | 56% | 61% | +1.6% |
| Big down day | 45 | 62% | 61% | +4.2% |
| RSI rises above 70 | 41 | 56% | 61% | +4.7% |
| Crosses above 200-day avg | 37 | 70% | 61% | +5.6% |
| New 52-week high | 37 | 51% | 61% | +0.7% |
| Down streak | 36 | 64% | 61% | +3.3% |
| Falls below 200-day avg | 33 | 85% | 61% | +4.1% |
| Big up day | 31 | 55% | 61% | +1.8% |
| Volume spike on a down day | 30 | 67% | 61% | +3.8% |
| RSI drops below 30 | 26 | 85% | 61% | +5.6% |
| Squeeze breakout up | 22 | 55% | 61% | +4.0% |
| Gap down | 21 | 71% | 61% | +5.6% |
ZOSH shows history and calculations for learning. It is not investment advice and does not tell anyone to buy or sell. Data: Yahoo Finance, AMFI, NSE and official sources; it can be late or wrong, so check before acting.